115 related articles for article (PubMed ID: 24844139)
1. Tryptophan hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis.
Fu HJ; Zhou YR; Bao BH; Jia MX; Zhao Y; Zhang L; Li JX; He HL; Zhou XM
J Med Chem; 2014 Jun; 57(11):4692-709. PubMed ID: 24844139
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid derivatives as bone anabolic agents targeted to tryptophan hydroxylase 1 (Tph-1).
Fu HJ; Zhao Y; Zhou YR; Bao BH; Du Y; Li JX
Eur J Pharm Sci; 2015 Aug; 76():33-47. PubMed ID: 25930119
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of serotonin inhibition in mouse models of bone loss.
Inose H; Zhou B; Yadav VK; Guo XE; Karsenty G; Ducy P
J Bone Miner Res; 2011 Sep; 26(9):2002-11. PubMed ID: 21608033
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure-activity relationship of thienopyridine derivatives as bone anabolic agents.
Saito K; Nakao A; Shinozuka T; Shimada K; Matsui S; Oizumi K; Yano K; Ohata K; Nakai D; Nagai Y; Naito S
Bioorg Med Chem; 2013 Apr; 21(7):1628-42. PubMed ID: 23453217
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.
Yadav VK; Balaji S; Suresh PS; Liu XS; Lu X; Li Z; Guo XE; Mann JJ; Balapure AK; Gershon MD; Medhamurthy R; Vidal M; Karsenty G; Ducy P
Nat Med; 2010 Mar; 16(3):308-12. PubMed ID: 20139991
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
[TBL] [Abstract][Full Text] [Related]
7. Discovery of coumarin-dihydropyridine hybrids as bone anabolic agents.
Sashidhara KV; Kumar M; Khedgikar V; Kushwaha P; Modukuri RK; Kumar A; Gautam J; Singh D; Sridhar B; Trivedi R
J Med Chem; 2013 Jan; 56(1):109-22. PubMed ID: 23214410
[TBL] [Abstract][Full Text] [Related]
8. Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.
Jin H; Cianchetta G; Devasagayaraj A; Gu K; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; David Kimball S; Main AJ; Ding ZM; Sun W; Yang Q; Yu XQ; Powell DR; Wilson A; Liu Q; Shi ZC
Bioorg Med Chem Lett; 2009 Sep; 19(17):5229-32. PubMed ID: 19631532
[TBL] [Abstract][Full Text] [Related]
9. Substituted benzothiophene or benzofuran derivatives as a novel class of bone morphogenetic protein-2 up-regulators: synthesis, structure-activity relationships, and preventive bone loss efficacies in senescence accelerated mice (SAMP6) and ovariectomized rats.
Guo HF; Shao HY; Yang ZY; Xue ST; Li X; Liu ZY; He XB; Jiang JD; Zhang YQ; Si SY; Li ZR
J Med Chem; 2010 Feb; 53(4):1819-29. PubMed ID: 20088515
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotective effects of Cimicifuga racemosa and its triterpene-saponins are responsible for reduction of bone marrow fat.
Seidlova-Wuttke D; Stecher G; Kammann M; Haunschild J; Eder N; Stahnke V; Wessels J; Wuttke W
Phytomedicine; 2012 Jul; 19(10):855-60. PubMed ID: 22739411
[TBL] [Abstract][Full Text] [Related]
11. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
[TBL] [Abstract][Full Text] [Related]
12. Modulation of peripheral serotonin levels by novel tryptophan hydroxylase inhibitors for the potential treatment of functional gastrointestinal disorders.
Shi ZC; Devasagayaraj A; Gu K; Jin H; Marinelli B; Samala L; Scott S; Stouch T; Tunoori A; Wang Y; Zang Y; Zhang C; Kimball SD; Main AJ; Sun W; Yang Q; Nouraldeen A; Yu XQ; Buxton E; Patel S; Nguyen N; Swaffield J; Powell DR; Wilson A; Liu Q
J Med Chem; 2008 Jul; 51(13):3684-7. PubMed ID: 18557609
[TBL] [Abstract][Full Text] [Related]
13. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
García-Osta A; Del Río J; Frechilla D
Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
[TBL] [Abstract][Full Text] [Related]
14. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques.
Sanchez RL; Reddy AP; Centeno ML; Henderson JA; Bethea CL
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):194-203. PubMed ID: 15857682
[TBL] [Abstract][Full Text] [Related]
15. Knockout mouse points to second form of tryptophan hydroxylase.
Veenstra-VanderWeele J; Cook EH
Mol Interv; 2003 Mar; 3(2):72-5, 50. PubMed ID: 14993427
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system.
Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
Behav Brain Res; 2009 Mar; 198(1):142-8. PubMed ID: 19046994
[TBL] [Abstract][Full Text] [Related]
17. Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion.
Ljubic-Thibal V; Morin A; Diksic M; Hamel E
Synapse; 1999 Jun; 32(3):177-86. PubMed ID: 10340628
[TBL] [Abstract][Full Text] [Related]
18. Antiosteoporotic activity of echinacoside in ovariectomized rats.
Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
[TBL] [Abstract][Full Text] [Related]
19. [Control of bone remodeling by nervous system. The role of serotonin in the regulation of bone metabolism].
Inose H
Clin Calcium; 2010 Dec; 20(12):1850-956. PubMed ID: 21123937
[TBL] [Abstract][Full Text] [Related]
20. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
